MONTREAL, QC – May 29, 2024 – MY01, an innovative medical technology company dedicated to revolutionizing the diagnosis of compartment syndrome, is proud to announce its expansion into the United Kingdom through a strategic partnership with LEDA Orthopaedics.
This partnership will create significant value for patients, providers, and payers in the UK by expanding the reach of MY01’s innovative continuous compartmental pressure monitor.
“We are thrilled to welcome LEDA Orthopaedics to the MY01 family,” said Charles Allan, CEO of MY01. Their extensive experience and commitment to providing differentiated solutions through education align with our mission to create a new standard of care. This partnership will significantly help us build and strengthen our presence in the UK.”
David Plane, Director at LEDA Orthopaedics, commented on the partnership: “As a medical device distributor that prides itself on introducing healthcare technology that truly improves patient care, all of us at LEDA are delighted to partner with MY01. Their commitment to professional education and product excellence makes MY01 a perfect fit within the LEDA portfolio, and we cannot wait to introduce this device to UK surgeons and their patients.”
About LEDA Orthopaedics
LEDA Orthopaedics is an independently run, British orthopedic distribution company, established in 2013 with a focus on providing high-quality products and high levels of service to their customers. As a leading medical device distributor, they’re committed to introducing advanced healthcare technologies that improve patient care. Based in the United Kingdom, LEDA Orthopaedics prides itself on its dedication to professional education and product excellence.
About MY01, Inc
MY01, Inc. is a privately held commercial-stage medical technology company on a mission to empower healthcare professionals with objective data to aid in the diagnosis of compartment syndrome, thereby improving patient outcomes. MY01 believes that incorporating actionable, quantitative data at the bedside can augment clinical assessments and provide more effective care. Since its establishment in 2015, MY01, Inc., headquartered in Montreal, Quebec, has leveraged its expertise in microsensing technology to provide innovative diagnostic solutions.